Binding of the non-classical cannabinoid CP 55,940, and the diarylpyrazole AM251 to rodent brain cannabinoid receptors

Life Sciences

Volumn 61, Issue 14, 1997, Pages

  Gatley, S John ^a   Lan, Ruoxi ^b   Pyatt, Beatrice ^a   Gifford, Andrew N ^a   Volkow, Nora D ^a   Makriyannis, Alexandros ^b  

^a BROOKHAVEN NATIONAL LABORATORY   (United States)

^b UNIVERSITY OF CONNECTICUT   (United States)

Author keywords

AM251; Brain; Cannabinoid receptor binding; CP 55,940

Indexed keywords

1 (2,4 DICHLOROPHENYL) 5 (4 IODOPHENYL) 4 METHYL N (1 PIPERIDYL) 1H PYRAZOLE 3 CARBOXAMIDE; 2,3 DIHYDRO 5 METHYL 3 (MORPHOLINOMETHYL) 6 (1 NAPHTHOYL)PYRROLO[1,2,3 DE][1,4]BENZOXAZINE; 4 (1,1 DIMETHYLHEPTYL) 1',2',3',4',5',6' HEXAHYDRO 2,3' DIHYDROXY 6' (3 HYDROXYPROPYL)BIPHENYL; CANNABINOID; CANNABINOID RECEPTOR; METHANANDAMIDE; RIMONABANT; TETRAHYDROCANNABINOL; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; AUTORADIOGRAPHY; BRAIN; BRAIN REGION; CEREBELLUM; CONTROLLED STUDY; CORPUS STRIATUM; DRUG RECEPTOR BINDING; HIPPOCAMPUS; MALE; MOUSE; NONHUMAN; RAT; SCATCHARD PLOT; SPECIES DIFFERENCE;

ANIMALS; AUTORADIOGRAPHY; BRAIN; CYCLOHEXANOLS; IODINE RADIOISOTOPES; MALE; MICE; PIPERIDINES; PROTEIN BINDING; PYRAZOLES; RADIOLIGAND ASSAY; RATS; RECEPTORS, CANNABINOID; RECEPTORS, DRUG;

ANIMALIA; RODENTIA;

EID: 4143108422     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0024-3205(97)00690-5     Document Type: Article

References (16)

1. R. LAN, S.J. GATLEY and A. MAKRIYANNIS, J. Label Cmpds. 38 875-881 (1996).
2. S.J. GATLEY, A.N. GIFFORD, N.D. VOLKOW, R. LAN and A. MAKRIYANNIS, Eur. J. Pharmacol. 307 301-308 (1996).
3. W.A. DEVANE, F.A. DYSARZ, M.R. JOHNSON, L.S. MELVIN and A.C. HOWLETT, Mol. Pharmacol. 34 605-613 (1988).
4. M. RINALDI-CARMONA, F. BARTH, M. HEAULME, D. SHIRE, B. CALANDRA, C. CONGY, S. MARTINEZ, J. MARUANI, G. NELIAT, D. CAPUT, P. FERRARA, P. SOUBRIE, J.C. BRELIERE and G. LEFUR, FEBS Lett. 350 240-244 (1994).
5. Y. GAONI and R. MECHOULAM, J. Am. Chem, Soc. 86 1646-1647 (1964).
6. J. ROMERO, E. GARCÍA-PALOMERO, S.Y. LIN, J.A. RAMOS, A. MAKRIYANNIS and J.J. FERNÁNDEZ-RUIZ, Life Sci 58 1249-1257 (1996).
7. T.E. D'AMBRA, K.G. ESTEP, M.R. BELL, M.A. EISSENSTAT, K.A. JOSEF, S.J. WARD, D.A. HAYCOCK, E.R. BAIZMAN, F.M. CASIANO, N.C. BEGLIN, S.M. CHIPPARI, J.D. GREGO, R.K. KULLNIG and G.T. DALEY, J Med Chem 35 124-135 (1992).
8. P.J. LITTLE, D.R. COMPTON, M.R. JOHNSON, L.S. MELVIN and B.R. MARTIN, J Pharmacol Exp Ther 247 1046-1051 (1988).
9. L.S. MELVIN, M.R. JOHNSON, C.A. HARBERT, G.M. MILNE and A. WEISSMAN, J Med Chem 27 67-71 (1984).
10. M. HERKENHAM, A.B. LYNN, M.D. LITTLE, M.R. JOHNSON, L.S. MELVIN, B.R. DECOSTA and K.C. RICE, Proc. Natl. Acad. Sci. 87 1932-1936 (1990).
11. M. HERKENHAM, A.B. LYNN, M.R. JOHNSON, L.S. MELVIN, B.R. DECOSTA and K.C. RICE, J. Neurosci. 11 563-583 (1991).
12. B.F. THOMAS, X. WEI and B.R. MARTIN, J Pharmacol Exp Ther 263 133-1390 (1992).
13. E.M. JANSEN, D.A. HAYCOCK, S.J. WARD and V.S. SEYBOLD, Brain Res 575 93-102 (1992).
14. Z.H. SONG and T.I. BONNER, Mol. Pharmacol. 49 891-896 (1996).
15. M. RINALDI-CARMONA, F. PIALOT, C. CONGY, E. REDON, F. BARTH, A. BACHY, J.C. BRELIERE, P. SOUBRIE and G. LEFUR, Life Sci. 58 1239-1247 (1996).
16. A. CHARALAMBOUS, G. MARCINIAK, C.Y. SHIUE, S.L. DEWEY, D.J. SCHLYER, A.P. WOLF and A. MAKRIYANNIS, Pharmacol. Biochem. Behav. 40 503-507 (1991).